Brian Skorney

Q: What is Brian Skorney's success rate?

Brian Skorney currently has a success rate of 91.92653037238163.

Q: What is the average return of Brian Skorney's calls?

Their stock ratings have generated an average return of 27.166134611114796.

Baird | Healthcare

Brian Skorney is an analyst from Baird specializing in the Healthcare sector. Ranked #770 out of 4773 analysts, they have issued 15 stock ratings with a success rate of 91.93% and an average return of 27.17%.

With 15 ratings to date, Brian Skorney is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 91.93% and an average return of 27.17%, highlighting promising potential as their track record develops further.

#770

Out of 4773

Total Ratings

+91.93%

Success Rate

+27.17%

Average Return

Recent Ratings Analysis

DYN

Buy

Sep 09, 2026

Target

$30.00

Current

$18.21

Performance

-5.11%

Brian Skorney rated DYN as Outperform on Sep 09, 2026, setting a price target of 30. The stock has underperformed, dropping 5.11% despite the bullish target of 30.

VRTX

Sell

Jul 07, 2026

Target

$350.00

Current

$515.44

Performance

-1.30%

On Jul 07, 2026, VRTX was given a Underperform rating by Brian Skorney, with a target price of 350. The stock traded sideways with only a -1.30% move, leaving the Sell case unresolved.

CRNX

Buy

Jul 07, 2026

Target

$85.00

Current

$84.95

Performance

1.70%

CRNX received a Outperform rating from Brian Skorney on Jul 07, 2026, aiming for 85. Price action was muted, as shares hovered around 84.95 despite the bullish outlook.

RGNX

Buy

Jun 22, 2026

Target

$32.00

Current

$8.53

Performance

-5.95%

On Jun 22, 2026, Brian Skorney published a Outperform outlook on RGNX, with a target of 32. Market action contradicted the Buy thesis, as shares slipped to 8.53.

ANRO

Buy

May 18, 2026

Target

$36.00

Current

$32.00

Performance

46.79%

Brian Skorney on May 18, 2026 assigned ANRO a Outperform rating, with a price target of 36. The Buy call aligned well with market performance, producing a gain of 46.79%.

MIRM

Buy

May 07, 2026

Target

$129.00

Current

$98.22

Performance

-4.58%

On May 07, 2026, Brian Skorney reaffirmed MIRM with a Outperform rating, targeting 129. Market indecision has kept the 129 target in a holding pattern.

XENE

Buy

Mar 09, 2026

Target

$97.00

Current

$58.65

Performance

-6.55%

XENE was rated Outperform by Brian Skorney on Mar 09, 2026, with a price objective of 97. This case shows how bullish projections can fail, with the stock now below 58.65.

SRPT

Hold

Nov 04, 2025

Target

$15.00

Current

$20.45

Performance

26.23%

On Nov 04, 2025, Brian Skorney initiated coverage on SRPT with a Neutral rating and target of 15. The Hold stance underestimated the stock’s strength as it gained 26.23%.

BHVN

Buy

Aug 12, 2025

Target

$52.00

Current

$12.71

Performance

-5.64%

Brian Skorney issued a Outperform recommendation for BHVN on Aug 12, 2025, price target set at 52. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

SLNO

Buy

Jul 11, 2025

Target

$121.00

Current

$53.01

Performance

-35.01%

On Jul 11, 2025, SLNO was evaluated by Brian Skorney, who gave a Outperform rating and target of 121. Investors saw limited payoff as shares fell short of the 121 target.

REGN

Hold

Feb 05, 2025

Target

$759.00

Current

$781.49

Performance

9.04%

Brian Skorney rated REGN as Neutral on Feb 05, 2025, setting a price target of 759. Despite the Hold call, shares climbed 9.04% to 781.49, revealing unexpected momentum.

BNTC

Buy

Dec 13, 2024

Target

$30.00

Current

$12.19

Performance

3.57%

On Dec 13, 2024, BNTC was given a Outperform rating by Brian Skorney, with a target price of 30. The stock traded sideways with a 3.57% move, keeping the bullish thesis unresolved.

APLT

Buy

Nov 29, 2024

Target

$5.00

Current

$0.10

Performance

-94.93%

APLT received a Outperform rating from Brian Skorney on Nov 29, 2024, aiming for 5. The rating hasn’t played out as hoped, with the stock trading 94.93% below expectations.

ENTA

Buy

Nov 26, 2024

Target

$20.00

Current

$12.96

Performance

51.40%

On Nov 26, 2024, Brian Skorney published a Outperform outlook on ENTA, with a target of 20. Shares gained 51.40%, underscoring the accuracy of the bullish outlook toward 20.

BIIB

Buy

Nov 15, 2024

Target

$300.00

Current

$217.15

Performance

35.73%

Brian Skorney on Nov 15, 2024 assigned BIIB a Outperform rating, with a price target of 300. The Buy call aligned well with market performance, producing a gain of 35.73%.

AMGN

Sell

Sep 25, 2024

Target

$215.00

Current

$377.35

Performance

20.61%

On Sep 25, 2024, Brian Skorney reaffirmed AMGN with a Underperform rating, targeting 215. The Sell recommendation anticipated weakness, as shares dropped 20.61%.

NBIX

Buy

Aug 02, 2024

Target

$180.00

Current

$156.22

Performance

2.01%

NBIX was rated Outperform by Brian Skorney on Aug 02, 2024, with a price objective of 180. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

GILD

Hold

Jun 20, 2024

Target

$80.00

Current

$143.72

Performance

109.84%

On Jun 20, 2024, Brian Skorney initiated coverage on GILD with a Neutral rating and target of 80. The Hold stance underestimated the stock’s strength as it gained 109.84%.

LXEO

Buy

Jun 13, 2024

Target

$28.00

Current

$4.25

Performance

-77.35%

Brian Skorney issued a Outperform recommendation for LXEO on Jun 13, 2024, price target set at 28. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Frequency Asked Questions

Who is Brian Skorney?

Brian Skorney is an analyst from Baird specializing in the Healthcare sector.

What is Brian Skorney's success rate?

Brian Skorney currently has a success rate of +91.93%.

How many ratings has Brian Skorney issued?

Brian Skorney has issued 15 stock ratings so far.

What is the average return of Brian Skorney's calls?

Their stock ratings have generated an average return of +27.17%.

What is Brian Skorney's ranking?

Brian Skorney is ranked #770 out of 4773 analysts.

What types of ratings does Brian Skorney give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Brian Skorney?

You can follow Brian Skorney by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Brian Skorney?

Their latest rating was a Buy on DYN issued on 2026-09-09.